The challenges for cardiac vascular precursor cell therapy: Lessons from a very elusive precursor

Journal of Vascular Research

Volumn 50, Issue 4, 2013, Pages 304-323

  Roura, Santiago ^a   Gálvez Montón, Carolina ^a   Bayes Genis, Antoni ^b,c  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Angiogenesis; Cardiac regeneration; Endothelial cell; Endothelium; Vascular precursor cell; Vasculogenesis

Indexed keywords

ANGIOGENESIS; CARDIAC STEM CELLL TRANSPLANTATION; CELL LINEAGE; CELL PROLIFERATION; CELL REGENERATION; CLONOGENESIS; HUMAN; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM;

EID: 84880183152     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000353294     Document Type: Review

References (200)

1. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM: Endothelial cells in physiology and in the pathophysiology of vascular disorDers. Blood 1998; 91: 3527-35261
2. Cleland JG, Khand A, Clark A: The heart failure epiDemic: exactly how big is it? Eur Heart J 2001; 22: 623-626
3. Pfeffer MA, Braunwald E: Ventricular remoDeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81: 1161-1172
4. Anversa P, Kajstura J: Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1-14
5. Beltrami A, Urbanek K, Kajstura J, Jan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: EviDence that human cardiac myocytes diviDe after myocardial infarction. N Engl J Med 2001; 344: 1750-1757
6. Anversa P, Nadal-Ginard B: Myocyte renewal and ventricular remoDelling. Nature 2002; 415: 240-243
7. Soler-Botija C, Bag JR, Bayes-Genis A: A birds-eye view of cell therapy and tissue engineering for cardiac regeneration. Ann NY Acad Sci 2012; 1254: 57-65
8. Laflamme MA, Myerson D, Saffitz JE, Murry CE: EviDence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002; 90: 634-640
9. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15
10. Caplice NM, Deb A: Myocardial-cell replacement: the science, the clinic and the future. Nat Clin Pract Cardiovasc Med 2004; 1: 90-95
11. Dimmeler S, Zeiher AM, SchneiDer MD: Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-583
12. Menasche P: Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives. Thromb Haemost 2005; 94: 697-701
13. Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR: Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 2011; 13: 245-267
14. Urbich C, Dimmeler S: Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004; 14: 318-322
15. Urbich C, Dimmeler S: Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-353
16. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, Allidina Y, Liu P, Li RK: Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002; 123: 1132-1140
17. Cleland JG, Freemantle N, Coletta P, Clark AL: Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 2006; 8: 105-110
18. Fishman AP: Endothelium: a distributed organ of diverse capabilities. Ann NY Acad Sci 1982; 401: 1-8
19. Edgington T: Vascular biology: integrated molecular cell biology. FASEB J 1995; 9: 841-842
20. Rodgers GM: Hemostatis properties of normal and perturbed vascular cells. FASEB J 1998; 2: 116-123
21. Triggle CR, Samuel SM, Ravishankar S, Marei I, Arunachalam G, Ding H: The endothelium: influencing vascular smooth muscle in many ways. Can J Physiol Pharmacol 2012; 90: 713-738
22. BranDes RP, Fleming I, Busse R: Endothelial aging. Cardiovasc Res 2005; 66: 286-294
23. Altschul R: Endothelium: its Development, morphology, function, and pathology. J Am Med Assoc 1955; 157: 691
24. Davies PF, Remuzzi A, Gordon EJ, Dewey CF Jr, Gimbrone MA Jr: Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci USA 1986; 83: 2114-2117
25. Davies PF, Robotewskyj A, Griem ML: Endothelial cell adhesion in real time: measurements in vitro by tanDem scanning confocal image analysis. J Clin Invest 1993; 91: 2640-2652
26. Pan S: Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress. Antioxid Redox Signal 2009; 11: 1669-1682
27. Hennig T, Mogensen C, Kirsch J, Pohl U, Gloe T: Shear stress induces the release of an endothelial elastase: role in integrin α v β 3-mediated FGF-2 release. J Vasc Res 2011; 48: 453-464
28. Reneman RS, Arts T, Hoeks AP: Wall shear stress-An important Determinant of endothelial cell function and structure-in the arterial system in vivo: discrepancies with theory. J Vasc Res 2006; 43: 251-269
29. Schmidt A, Brixius K, Bloch W: Endothelial precursor cell migration during vasculogenesis. Circ Res 2007; 101: 125-136
30. Risau W: Mechanisms of angiogenesis. Nature 1997; 386: 671-674
31. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
32. Rafii S, LyDen D: Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712
33. Asahara T, Murohara T, Sullivan A, Silver M, van Der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967
34. Shi Q, Raffi S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: EviDence of circulating bone marrow-Derived endothelial cells. Blood 1998; 92: 362-367
35. De Spiegelaere W, Casteleyn C, Van Den Broeck W, Plendl J, Bahramsoltani M, Simoens P, Djonov V, Cornillie P: Intussusceptive angiogenesis: a biologically relevant form of angiogenesis. J Vasc Res 2012; 49: 390-404
36. Short RHD: Alveolar epithelium in relation to growth of the lung. Philos Trans R Soc Lond B Biol Sci 1950; 235: 35-87
37. Anggard E: Nitric oxiDe: mediator, murDerer, and medicine. Lancet 1994; 343: 1199-1206
38. Toda N, Okamura T: Modulation of renal blood flow and vascular tone by neuronal nitric oxiDe synthase-Derived nitric oxiDe. J Vasc Res 2011; 48: 1-10
39. McQuillan LP, Leung GK, MarsDen PA, Kostyk SK, Kourembanas S: Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994; 267:H1921-H1927
40. Landry DW, Olivier JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595
41. Kondo T, Kobayashi K, Murohara T: Nitric oxiDe signaling during myocardial angiogenesis. Mol Cell Biochem 2004; 264: 25-34
42. Graven KK, Zimmerman LH, Dickson EW, Weinhouse GL, Farber HW: Endothelial cell hypoxia associated proteins are cell and stress specific. J Cell Physiol 1993; 157: 544-554
43. Karimova A, Pinsky DJ: The endothelial response to oxygen Deprivation: biology and clinical implications. Intensive Care Med 2001; 27: 19-31
44. Semenza GL: Hypoxia-inducible factor 1: master regulator of O 2 homeostasis. Curr Opin Genet Dev 1998; 8: 588-594
45. Semenza GL: Hypoxia response elements in the aldolase A, enolase 1, and lactate Dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996; 271: 32529-32537
46. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassman M, Gearhart JD, Lawler AM, Yu AY, Semenza GL: Cellular and Developmental control of O 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 1998; 15: 149-162
47. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, OShea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442
48. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S: Vascular trauma induces rapid but transient mobilization of VEGFR2+CD133+ endothelial precursor cells. Circ Res 2001; 88: 167-174
49. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-Derived EPCs. EMBO J 1999; 18: 3964-3972
50. Herbrig K, Pistrosch F, Oelschlaegel U, Wichmann G, Wagner A, Foerster S, Richter S, Gross P, Passauer J: Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849
51. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779
52. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z: Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res 2005; 42: 408-414
53. Wojakowski W, TenDera M, Michalowska A, Majka M, Kucia M, Malankiewicz K, WyDerka R, Ochala A, Ratajczak MZ: Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110: 3213-3220
54. Wojakowski W, TenDera M, Kucia M, Zuba-Surma E, Paczkowska E, Ciosek J, Halasa M, Krl M, Kazmierski M, Buszman P, Ochala A, Ratajczak J, Machaliski B, Ratajczak MZ: Mobilization of bone marrowDerived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009; 53: 1-9
55. WyDerka R, Wojakowski W, Jadczyk T, Malankiewicz K, Parma Z, Pawlowski T, Musialek P, Majka M, Krl M, Kuczmik W, Dworowy S, Korzeniowska B, Ratajczak MZ, TenDera M: Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remoDeling in 1-year follow-up of patients with acute myocardial infarction. Mediators Inflamm 2012; 2012: 564027
56. Nagai T, Komuro I: Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function. Am J Physiol Heart Circ Physiol 2012; 303:H501-H512
57. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG: Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005; 46: 7-18
58. Shantsila E, Watson T, Lip GY: Endothelial progenitor cells in cardiovascular disorDers. J Am Coll Cardiol 2007; 49: 741-752
59. Foresta C, Lana A, Cabrelle A, Ferigo M, Caretta N, Garolla A, Palu G, Ferlin A: PDE-5 inhibitor, VarDenafil, increases circulating progenitor cells in humans. Int J Impot Res 2005; 74: 377-380
60. Zhu JH, Wang XX, Chen JZ, Shang YP, Zhu JH, Guo XG, Sun J: Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 2004; 8: 1045-1051
61. Chen J, Wang X, Zhu J, Shang Y, Guo X, Sun J: Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood. J Cardiovasc Pharmacol 2004; 43: 347-352
62. Petit I, Jin D, Rafii S: The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-Angiogenesis. Trends Immunol 2007; 28: 299-307
63. Lee SP, Youn SW, Cho HJ, Li L, Kim TY, Yook HS, Chung JW, Hur J, Yoon CH, Park KW, Oh BH, Park YB, Kim HS: Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 2006; 114: 150-159
64. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E, Kobayashi K, Tongers J, Roncalli J, Tsurumi Y, Hagiwara N, Losordo DW: CXCR4 blockaDe augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 2010; 107: 11008-11013
65. Pusic I, DiPersio JF: Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol 2010; 17: 319-326
66. De Clercq E: Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil TM ) and potential of other CXCR4 antagonists as stem cell mobilizers. Pharmacol Ther 2010; 128: 509-518
67. De Clercq E: The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochem Pharmacol 2009; 77: 1655-1664
68. Chen J, Lopez JA: Interactions of platelets with subendothelium and endothelium. Microcirculation 2005; 12: 235-246
69. Stellos K, Gawaz M: Platelets and stromal cellDerived factor-1 in progenitor cell recruitment. Semin Thromb Hemost 2007; 33: 159-164
70. Anand S: A brief primer on microRNAs and their roles in angiogenesis. Vasc Cell 2013; 5: 2
71. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G: MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006; 108: 3068-3071
72. Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, Ramakrishnan S: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest 2010; 120: 4141-4154
73. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA: MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 2010; 16: 909-914
74. Shah VK, Shalia KK: Stem cell therapy in acute myocardial infarction: a pot of gold or Pandoras box. Stem Cells Int 2011; 2011: 536758
75. Bayes-Genis A, Roura S, Prat-Vidal C, Farre J, Soler-Botija C, De Luna AB, Cinca J: Chimerism and microchimerism of the human heart: eviDence for cardiac regeneration. Nat Clin Pract Cardiovasc Med 2007; 4(suppl 1):S40-S45
76. Tilemann L, Ishihawa K, Weber T, Hajjar RJ: Gene therapy for heart failure. Circ Res 2012;110:777-793
77. Said SS, Pickering JG, Mequanint K: Advances in growth factor Delivery for therapeutic angiogenesis. J Vasc Res 2013; 50: 35-51
78. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J, Fiumana E, Rastaldo R, Arcarese ML, Mitchell TS, Boni A, Bolli R, Urbanek K, Hosoda T, Anversa P, Leri A, Kajstura J: Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008; 103: 107-116
79. Lionetti V, Ventura C: Regenerative medicine approach to repair the failing heart. Vascul Pharmacol 2013; 58: 159-163
80. Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, Martens TP, Radisic M: Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 2010; 16: 169-187
81. Chavakis E, Koyanagi M, Dimmeler S: Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedsiDe and back. Circulation 2010; 121: 325-335
82. Strauer BE, Steinhoff G: 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 2011; 58: 1095-1104
83. Shiba Y, FernanDes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE, Laflamme MA: Human ES-cell-Derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012; 489: 322-325
84. Heng BC, HaiDer HK, Sim EK, Cao T, Tong GQ, Ng SC: Comments about possible use of human embryonic stem cell-Derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage. Acta Cardiol 2005; 60: 7-12
85. Cao F, van Der Bogt KE, SadrzaDeh A, Xie X, Sheikh AY, Wang H, Connolly AJ, Robbins RC, Wu JC: Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 2007; 16: 883-891
86. Maulik N, Thirunavukkarasu M: Growth factors and cell therapy in myocardial regeneration. J Mol Cell C-Ardiol 2008; 44: 219-227
87. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S: Neovascularization of ischemic myocardium by human bone-marrow-Derived angioblasts prevents cardiomyocyte apoptosis, reduces remoDeling and improves cardiac function. Nat Med 2001; 7: 430-436
88. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349
89. Badorff C, BranDes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S: Transdifferentiation of blood-Derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003; 107: 1024-1032
90. Koyanagi M, HaenDeler J, Badorff C, BranDes RP, Hoffmann J, Pandur P, Zeiher AM, Khl M, Dimmeler S: Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J Biol Chem 2005; 280: 16838-16842
91. Gruh I, Beilner J, Blomer U, Schmiedl A, Schmidt-Richter I, Kruse ML, Haverich A, Martin U: No eviDence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006; 113: 1326-1334
92. Cho HJ, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, Jeong JO, Curry C, Qin G, Yoon YS: Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 2007; 204: 3257-3269
93. Young PP, Vaughan DE, Hatzopoulos AK: Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007; 49: 421-429
94. Park JH, Yoon JY, Ko SM, Jin SA, Kim JH, Cho CH, Kim JM, Lee JH, Choi SW, Seong IW, Jeong JO: Endothelial progenitor cell transplantation Decreases lymphangiogenesis and adverse myocardial remoDeling in a mouse moDel of acute myocardial infarction. Exp Mol Med 2011; 43: 479-485
95. Ingram DA, Mead LE, Tanaka H, MeaDe V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, YoDer MC: IDentification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760
96. Pohl D, Meininger G: Editorial. J Vas Res 2012; 49: 1
97. Hirschi KK, Ingram DA, YoDer MC: Assessing iDentity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-1595
98. Favre J, Terborg N, Horrevoets AJ: The diverse iDentity of angiogenic monocytes. Eur J Clin Invest 2013; 43: 100-107
99. Kovacic JC, Moore J, Herbert A, Ma D, Boehm M, Graham RM: Endothelial progenitor cells, angioblasts, and angiogenesis-old terms reconsiDered from a current perspective. Trends Cardiovasc Med 2008; 18: 45-51
100. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, LyDen D, Rafii S: Cytokine-mediated Deployment of SDF-1 induces revascularisation through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-567
101. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-189
102. Medina RJ, ONeill CL, ODoherty TM, Knott H, Guduric-Fuchs J, Gardiner TA, Stitt AW: Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med 2011; 17: 1045-1055
103. Berardi AC, Wang A, Abraham J, ScadDen DT: Basic fibroblast growth factor mediates its effects on committed myeloid progenitors by direct action and has no effect on hematopoietic stem cells. Blood 1995; 86: 2123-2129
104. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE Jr: Functional small-diameter neovessels created using endothelial progenitor cells expanDed ex vivo. Nat Med 2001; 7: 1035-1040
105. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N: Angiogenesis assays: a critical overview. Clin Chem 2003; 49: 32-40
106. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600
107. YoDer MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA: ReDefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801-1809
108. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jrgens K, Miche E, Bhm M, Nickenig G: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226
109. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H: Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxiDe synthase. Circulation 2004; 110: 1933-1939
110. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890
111. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288-293
112. Medina RJ, ONeill CL, Humphreys MW, Gardiner TA, Stitt AW: Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 5906-5913
113. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS: Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618-1627
114. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, RohDe E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, Strunk D: Humanized large-scale expanDed endothelial colony-forming cells function in vitro and in vivo. Blood 2009; 113: 6716-6725
115. Mund JA, Estes ML, YoDer MC, Ingram DA Jr, Case J: Flow cytometric iDentification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 2012; 32: 1045-1053
116. Hristov M, Erl W, Weber PC: Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185-1189
117. Boisset JC, Robin C: On the origin of hematopoietic stem cells: progress and controversy. Stem Cell Res 2012; 8: 1-13
118. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP: Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584-1590
119. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi SI, Isner JM, Asahara T: Vascular endothelial growth factor 165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000; 86: 1198-1202
120. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T: Transplanted cord blood-Derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536
121. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, Llach A, Hove-Madsen L, Pons Llad G, Farre J, Cinca J, Bayes-Genis A: Idiopathic dilated cardiomyopathy exhibits Defective vascularization and vessel formation. Eur J Heart Fail 2007; 9: 995-1002
122. Desai A, Glaser A, Liu D, Raghavachari N, Blum A, Zalos G, Lippincott M, McCoy JP, Munson PJ, Solomon MA, Danner RL, Cannon RO: Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol 2009; 29: 121-127
123. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T, Sekine I: Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 2003; 131: 536-540
124. Melero-Martin JM, Khan ZA, Picard A, Wu X, Paruchuri S, Bischoff J: In vivo vasculogenic potential of human blood-Derived endothelial progenitor cells. Blood 2007; 109: 4761-4768
125. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, Bischoff J: Engineering robust and functional vascular networks in vivo with human adult and cord blood-Derived progenitor cells. Circ Res 2008; 103: 194-202
126. Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM: Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant 2011; 20: 515-522
127. Smadja DM, Bieche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C, Vidaud M, Aiach M, Gaussem P: PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 2005; 25: 2321-2327
128. Smadja DM, LaurenDeau I, Avignon C, Vidaud M, Aiach M, Gaussem P: The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 2006; 4: 2051-2058
129. Smadja DM, Cornet A, Emmerich J, Aiach M, Gaussem P: Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol Toxicol 2007; 23: 223-239
130. Siegel DL: Selecting antibodies to cell-surface antigens using magnetic sorting techniques. Methods Mol Biol 2002; 178: 219-226
131. Perfetto SP, Chattopadhyay PK, RoeDerer M: Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004; 4: 648-655
132. Khan SS, Solomon MA, McCoy JP Jr: Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8
133. Duda DG, Cohen KS, ScadDen DT, Jain RK: A protocol for phenotypic Detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007; 2: 805-810
134. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K: Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001; 65: 845-847
135. Strauer BE, Brehm M, Zeus T, Kstering M, HernanDez A, Wernet P: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918
136. Assmus B, Schchinger V, Teupe C, Britten M, Lehmann R, Dbert N, Grnwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 2002; 106: 3009-3017
137. Schchinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44: 1690-1699
138. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schchinger V, Dimmeler S, Zeiher AM: Infarct remoDeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-2218
139. FernnDez-Aviles F, San Romn JA, Garca-FraDe J, FernnDez ME, Penarrubia MJ, De la Fuente L, Gmez-Bueno M, Cantalapiedra A, FernnDez J, Gutierrez O, Snchez PL, HernnDez C, Sanz R, Garca-Sancho J, Snchez A: Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-748
140. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 3619351: 45-46
141. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361: 47-49
142. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, BreiDenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148
143. LunDe K, Solheim S, Aakhus S, Arnesen H, AbDelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-1209
144. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators: Intracoronary bone marrow-Derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221
145. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators: Improved clinical outcome after intracoronary administration of bone-marrow-Derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIRAMI trial. Eur Heart J 2006; 27: 2775-2783
146. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, RaDemakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van De Werf F: Autologous bone marrow-Derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-121
147. Huikuri HV, Kervinen K, Niemel M, Ylitalo K, Sily M, Koistinen P, Savolainen ER, Ukkonen H, Pietil M, Airaksinen JK, Knuuti J, Mkikallio TH, FINCELL Investigators: Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008; 29: 2723-2732
148. Miettinen JA, Ylitalo K, Hedberg P, Jokelainen J, Kervinen K, Niemel M, Sily M, Koistinen P, Savolainen ER, Ukkonen H, Pietil M, Airaksinen KE, Knuuti J, Vuolteenaho O, Mkikallio TH, Huikuri HV: Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-Derived stem cells after thrombolytic therapy. Heart 2010; 96: 362-367
149. Miettinen JA, Salonen RJ, Niemel M, Kervinen K, Sily M, Koistinen P, Savolainen ER, Ukkonen H, Pietil M, Airaksinen KE, Knuuti J, Mkikallio TH, Huikuri HV, Ylitalo KV: Effects of intracoronary infusion of bone marrow-Derived stem cells on pulmonary artery pressure and diastolic function after myocardial infarction. Int J Cardiol 2010; 145: 631-633
150. Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, Zamini S, Khorsand A, Sochor H, Maurer G, Glogar D, Gyngysi M: Effect of intramyocardial Delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion: NOGA-guiDed subanalysis of the MYSTAR prospective randomised study. Thromb Haemost 2010; 103: 564-571
151. Hu S, Liu S, Zheng Z, Yuan X, Li L, Lu M, Shen R, Duan F, Zhang X, Li J, Liu X, Song Y, Wang W, Zhao S, He Z, Zhang H, Yang K, Feng W, Wang X: Isolated coronary artery bypass graft combined with bone marrow mononuclear cells Delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2011; 57: 2409-2415
152. Roncalli J, Mouquet F, Piot C, Trochu JN, Le Corvoisier P, NeuDer Y, Le Tourneau T, Agostini D, Gaxotte V, Sportouch C, Galinier M, Crochet D, Teiger E, Richard MJ, Polge AS, Beregi JP, Manrique A, Carrie D, Susen S, Klein B, Parini A, Lamirault G, Croisille P, Rouard H, Bourin P, Nguyen JM, Delasalle B, Vanzetto G, Van Belle E, Lemarchand P: Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J 2011; 32: 1748-1757
153. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, ForDer JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research Network: Effect of intracoronary Delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011; 306: 2110-2119
154. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, AnDerson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN): Effect of transendocardial Delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUSCCTRN trial. JAMA 2012; 307: 1717-1726
155. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, ForDer JR, AnDerson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN): Effect of the use and timing of bone marrow mononuclear cell Delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012; 308: 2380-2389
156. Hare JM, Fishman JE, Gerstenblith G, DiFeDe Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW: Comparison of allogeneic vs. autologous bone marrow-Derived mesenchymal stem cells Delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012; 308: 2369-2379
157. Ward MR, Stewart DJ, Kutryk MJ: Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 2007; 70: 983-998
158. Mund JA, Ingram DA, YoDer MC, Case J: Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy 2009; 11: 103-113
159. Taylor DA, Robertson MJ: The basics of cell therapy to treat cardiovascular disease: one cell does not fit all. Rev Esp Cardiol 2009; 62: 1032-1044
160. Taylor DA: Cell therapy: a 21st century hope for treating cardiovascular disease-A fiveyear retrospective and predictive view. Am Heart Hosp J 2011; 9:E24-E27
161. Senegaglia AC, Barboza LA, Dallagiovanna B, Aita CA, Hansen P, Rebelatto CL, Aguiar AM, Miyague NI, Shigunov P, Barchiki F, Correa A, Olandoski M, Krieger MA, Brofman PR: Are purified or expanDed cord blood-Derived CD133+ cells better at improving cardiac function Exp Biol Med (Maywood) 2010; 235: 119-129
162. SrDer D, Schwitter J, Moccetti T, Astori G, Rufibach K, Plein S, Lo Cicero V, Soncin S, WinDecker S, Moschovitis A, Wahl A, Erne P, Jamshidi P, Auf Der Maur C, Manka R, Soldati G, Bhler I, Wyss C, Landmesser U, Lscher TF, Corti R: Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study Design of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J 2010; 160: 58-64
163. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, Nguyen K, Rouy D, Altman P, Schwarz R, Mendizabal A, Oskouei B, Byrnes J, Soto V, Tracy M, Zambrano JP, Heldman AW, Hare JM: Rationale and Design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, doubleblind, placebo-controlled study of safety and efficacy. Am Heart J 2011; 161: 487-493
164. Pena-Duque MA, Martnez-Ros MA, CalDern GE, Meja AM, Gmez E, Martnez-Snchez C, Figueroa J, Gaspar J, Gonzlez H, Bialoztosky D, Meave A, Uribe-Gonzlez J, AlexnDerson E, Ochoa V, Masso F: Design and implementation of the TRACIA: intracoronary autologous transplant of bone marrow-Derived stem cells for acute ST elevation myocardial infarction. Arch Cardiol Mex 2011; 81: 183-187
165. Taljaard M, Ward MR, Kutryk MJ, Courtman DW, Camack NJ, Goodman SG, Parker TG, Dick AJ, Galipeau J, Stewart DJ: Rationale and Design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. Am Heart J 2010; 159: 354-360
166. Roura S, Bayes-Genis A: Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 2009; 6: 590-598
167. Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz W-M: Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 2007; 28: 1258-1264
168. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R: CD34+ and endothelial progenitor cells in patients with various Degrees of congestive heart failure. Circulation 2004; 110: 1209-1212
169. Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, Vrints CJ: Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 2010; 144: 350-366 .
170. Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R, Yokouchi K, Imai H, Harada M, Osanai H, Kondo T, Murohara T: The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006; 114:I114-I119
171. Alba AC, Delgado DH, Rao V, Walter S, Guyatt G, Ross HJ: Are endothelial progenitor cells a prognostic factor in patients with heart failure? Expert Rev Cardiovasc Ther 2012; 10: 167-175
172. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A: Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423-432
173. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH: Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004; 107: 273-280
174. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.Circulation 2002; 106: 2781-2786
175. Navarro-Sobrino M, Rosell A, HernanDez-Guillamon M, Penalba A, Rib M, Alvarez-Sabn J, Montaner J: Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010; 80: 317-323
176. Navarro-Sobrino M, HernnDez-Guillamon M, FernanDez-CaDenas I, Rib M, Romero IA, Couraud PO, Weksler BB, Montaner J, Rosell A: The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients. Vasc Cell 2013; 5: 3
177. Bayes-Genis A, Salido M, Sole Ristol F, Puig M, Brossa V, Camprecis M, Corominas JM, Marinoso ML, Bar T, Vela MC, Serrano S, Padr JM, Bayes De Luna A, Cinca J: Host cell-Derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res 2002; 56: 404-410
178. Bayes-Genis A, Muniz-Diaz E, Catasus L, Arilla M, Rodriguez C, Sierra J, Madoz PJ, Cinca J: Cardiac chimerism in recipients of peripheral-blood and bone marrow stem cells. Eur J Heart Fail 2004; 6: 399-402
179. Bayes-Genis A, Bellosillo B, De la Calle O, Salido M, Roura S, Ristol FS, Soler C, Martinez M, Espinet B, Serrano S, Bayes De Luna A, Cinca J: IDentification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heart. J Heart Lung Transplant 2005; 24: 2179-2183
180. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FW, Schoen FJ, Mayer JE Jr, Bischoff J: Tissue-engineered microvessels on three-dimensional bioDegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 2004; 287:H480-H487
181. Allen P, Melero-Martin J, Bischoff J: Type I collagen, fibrin and PuraMatrix matrices proviDe permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J Tissue Eng Regen Med 2011; 5:e74-e86
182. Camci-Unal G, Nichol JW, Bae H, Tekin H, Bischoff J, KhaDemhosseini A: Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells. J Tissue Eng Regen Med 2013; 17: 337-347
183. Melero-Martin JM, De Obaldia ME, Allen P, Dudley AC, Klagsbrun M, Bischoff J: Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. Tissue Eng Part A 2010; 16: 2457-2466
184. Lin RZ, Melero-Martin JM: Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature. Methods 2012; 56: 440-451
185. Lin RZ, Melero-Martin JM: Bioengineering human microvascular networks in immunoDeficient mice. J Vis Exp 2011; 53:e3065
186. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhuser M, Werner C: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377-384
187. Schmeckpeper J, Ikeda Y, Kumar AH, Metharom P, Russell SJ, Caplice NM: Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation 2009; 78: 169-176
188. Kumar AH, Caplice NM: Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 2010; 30: 1080-1087
189. Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Heydarkhan S, Xu Y, Zuk PA, MacLellan WR, Beygui RE: Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 2008; 187: 263-274
190. Roura S, Pujal JM, Bayes-Genis A: Umbilical cord blood for cardiovascular cell therapy: from promise to fact. Ann NY Acad Sci 2012; 1254: 66-70
191. Roura S, Bag JR, Soler-Botija C, Pujal JM, Glvez-Montn C, Prat-Vidal C, Llucia-VallDeperas A, Blanco J, Bayes-Genis A: Human umbilical cord blood-Derived mesenchymal stem cells promote vascular growth in vivo. PLoS One 2012; 7:e49447
192. Glvez-Montn C, Prat-Vidal C, Roura S, Soler-Botija C, Bayes-Genis A: Cardiac tissue engineering and the bioartificial heart. Rev Esp Cardiol 2013; 66: 391-399
193. Geti I, Ormiston ML, Rouhani F, Toshner M, Movassagh M, Nichols J, Mansfield W, Southwood M, Bradley A, Rana AA, Vallier L, Morrell NW: A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: bloodDerived endothelial progenitor cells. Stem Cells Transl Med 2012; 1: 855-865
194. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A: Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496-503
195. Timmermans F, Plum J, YDer MC, Ingram DA, VanDekerckhove B, Case J: Endothelial progenitor cells: iDentity Defined? J Cell Mol Med 2009; 13: 87-102
196. Pearson JD: Endothelial progenitor cells-An evolving story. Microvasc Res 2010; 79: 162-168
197. Richardson MR, YoDer MC: Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 2011; 50: 266-272
198. Pober JS: Just the FACS or stalking the elusive circulating endothelial progenitor cell. Arterioscler Thromb Vasc Biol 2012; 32: 837-838
199. Siddique A, Shantsila E, Lip GY, Varma C: Endothelial progenitor cells: what use for the cardiologist? J Angiogenes Res 2010; 2: 6
200. Tura O, Skinner EM, Barclay GR, Samuel K, Gallagher RC, Brittan M, Hadoke PW, Newby DE, Turner ML, Mills NL: Late outgrowth endothelial cells resemble mature endothelial cells and are not Derived from bone marrow. Stem Cells 2013; 31: 338-348. 324-331